By Huw Jones and Carolyn Cohn LONDON (Reuters) – The British government and the Bank of England are reforming insurers’…
Novartis weighs sale of ophthalmology, respiratory units – Bloomberg
(Reuters) -Swiss drugmaker Novartis AG is considering selling its ophthalmology and respiratory units, a Bloomberg report said on Wednesday, citing…
In Burnley, Britain’s cost of living crisis hits home
By Natalie Thomas BURNLEY, England (Reuters) – Skipping lunch each day and watching television in blankets to keep warm is…
Biden requests $9.25 billion for COVID, $37.7 billion for Ukraine from Congress -officials
By Jeff Mason WASHINGTON (Reuters) -The Biden administration is asking Congress for $9.25 billion to fight COVID-19 and an additional…
Exclusive-Carlyle seeks to line up bid for urgent care provider Heritage -sources
By David Carnevali NEW YORK (Reuters) – Carlyle Group Inc is in talks about putting together an acquisition offer for…
Big pharma not doing enough to improve drug access – analysis
By Natalie Grover LONDON (Reuters) – Since the pandemic emerged, more top drugmakers have made progress in improving access to…
White House to ask for $10 billion in public health funds by year end -report
(Reuters) – Officials from U.S. President Joe Biden’s administration are finalizing a request this week for about $10 billion in…
U.S. seeks 15 years for Elizabeth Holmes over Theranos fraud
By Akriti Sharma and Kanishka Singh (Reuters) – Theranos founder Elizabeth Holmes should spend 15 years in prison and pay…
Exclusive-Temasek considers sale of Advanced MedTech, likely valued at about $1 billion – sources
By Anshuman Daga and Yantoultra Ngui SINGAPORE (Reuters) – Temasek Holdings is exploring selling Advanced MedTech, multiple sources told Reuters…
Roche’s Alzheimer’s drug fails to meet goal in long awaited trial
By Ludwig Burger (Reuters) -Roche’s Alzheimer’s drug candidate could not be shown to slow dementia progression in two drug trials,…